Skip to content
10-K

Annual Report

Mangoceuticals, Inc. MGRX

0001493152-26-014478

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2026 16.97M sh
Shares Diluted FY 2025 · Dec 31, 2025 10.07M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.98M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$5.85M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.86M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.49M
Cash And Equivalents FY 2025 · Dec 31, 2024 $58.65K
Stockholders Equity FY 2025 · Dec 31, 2025 $15.2M
Stockholders Equity FY 2025 · Dec 31, 2024 $13.95M
Current Liabilities FY 2025 · Dec 31, 2025 $890.57K
Current Liabilities FY 2025 · Dec 31, 2024 $1.43M
Total Liabilities FY 2025 · Dec 31, 2025 $890.57K
Total Liabilities FY 2025 · Dec 31, 2024 $1.43M
Current Assets FY 2025 · Dec 31, 2025 $1.55M
Current Assets FY 2025 · Dec 31, 2024 $75.6K
Total Assets FY 2025 · Dec 31, 2025 $16.09M
Total Assets FY 2025 · Dec 31, 2024 $15.37M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.17
Eps Diluted restated FY 2025 · Dec 31, 2024 −$4.80
Eps Basic FY 2025 · Dec 31, 2025 −$2.17
Eps Basic restated FY 2025 · Dec 31, 2024 −$4.80
Sga Expense FY 2025 · Dec 31, 2025 $3.76M
Sga Expense FY 2025 · Dec 31, 2024 $3M
Net Income FY 2025 · Dec 31, 2025 −$20.64M
Net Income FY 2025 · Dec 31, 2024 −$8.71M
Operating Income FY 2025 · Dec 31, 2025 −$18.03M
Operating Income FY 2025 · Dec 31, 2024 −$7.97M
Gross Profit FY 2025 · Dec 31, 2025 $250.39K
Gross Profit FY 2025 · Dec 31, 2024 $379.96K
Cost Of Revenue FY 2025 · Dec 31, 2025 $54.42K
Cost Of Revenue FY 2025 · Dec 31, 2024 $93.3K
Revenue FY 2025 · Dec 31, 2025 $456.02K
Revenue FY 2025 · Dec 31, 2024 $615.87K